Caffeine

cytochrome P450, family 1, subfamily a, polypeptide 2 ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27712037 In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice. 2017 Feb 1
2 27434302 Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR. 2016 1
3 19520064 Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum. 2009 Aug 4 5
4 16141365 Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity. 2005 Dec 1
5 12110375 Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2. 2002 Jun 15 3
6 10570017 Detection of quantitative trait loci affecting caffeine metabolism by interval mapping in a genome-wide scan of C3H/HeJ x APN F(2) mice. 1999 Dec 2
7 9295056 Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity. 1997 Aug 2
8 9441719 Differences in caffeine 3-demethylation activity among inbred mouse strains: a comparison of hepatic Cyp1a2 gene expression between two inbred strains. 1997 Dec 1
9 8873215 Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2. 1996 Aug 6
10 17451311 Oxamniquine inhibits metabolism of caffeine, hexobarbitone and antipyrine in vivo in mice. 1996 Aug 1
11 7479582 Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (paracetamol) hepatotoxicity in mice without cytochrome P4501A2 inhibition. 1995 Jun 1